Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer

Jamie E. Chaft, Zhuoxin Sun, Charles M. Rudin, Onkar V. Khullar, Charles B. Simone, Kurt Oettel, David Kozono, Rajitha Sunkara, Bryan Faller, James M. Isbell, Vladimir Hugec, Asheesh Shipstone, Eric C. McGary, Jeffrey M. Clarke, Ashita Talsania, Li Ding, Ramaswamy Govindan, Jacob M. Sands, John V. Heymach, Luis E. Raez, Shakun M. Malik, Thomas E. Stinchcombe, Sumithra J. Mandrekar, Jeffrey Bradley, David E. Gerber, Everett Vokes, David Gandara, Charles Staley, Suresh S. Ramalingam

Open source

DOI
10.1001/jama.2026.8992
Published
2026-08-11
Container
JAMA
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2026.8992,
  title = {Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer},
  author = {Jamie E. Chaft and Zhuoxin Sun and Charles M. Rudin and Onkar V. Khullar and Charles B. Simone and Kurt Oettel and David Kozono and Rajitha Sunkara and Bryan Faller and James M. Isbell and Vladimir Hugec and Asheesh Shipstone and Eric C. McGary and Jeffrey M. Clarke and Ashita Talsania and Li Ding and Ramaswamy Govindan and Jacob M. Sands and John V. Heymach and Luis E. Raez and Shakun M. Malik and Thomas E. Stinchcombe and Sumithra J. Mandrekar and Jeffrey Bradley and David E. Gerber and Everett Vokes and David Gandara and Charles Staley and Suresh S. Ramalingam},
  year = {2026},
  journal = {JAMA},
  doi = {10.1001/jama.2026.8992},
  url = {https://doi.org/10.1001/jama.2026.8992}
}

RIS

TY  - JOUR
TI  - Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer
AU  - Jamie E. Chaft
AU  - Zhuoxin Sun
AU  - Charles M. Rudin
AU  - Onkar V. Khullar
AU  - Charles B. Simone
AU  - Kurt Oettel
AU  - David Kozono
AU  - Rajitha Sunkara
AU  - Bryan Faller
AU  - James M. Isbell
AU  - Vladimir Hugec
AU  - Asheesh Shipstone
AU  - Eric C. McGary
AU  - Jeffrey M. Clarke
AU  - Ashita Talsania
AU  - Li Ding
AU  - Ramaswamy Govindan
AU  - Jacob M. Sands
AU  - John V. Heymach
AU  - Luis E. Raez
AU  - Shakun M. Malik
AU  - Thomas E. Stinchcombe
AU  - Sumithra J. Mandrekar
AU  - Jeffrey Bradley
AU  - David E. Gerber
AU  - Everett Vokes
AU  - David Gandara
AU  - Charles Staley
AU  - Suresh S. Ramalingam
PY  - 2026
JO  - JAMA
DO  - 10.1001/jama.2026.8992
UR  - https://doi.org/10.1001/jama.2026.8992
ER  - 

APA

Chaft, J. E., Sun, Z., Rudin, C. M., Khullar, O. V., Simone, C. B., Oettel, K., Kozono, D., Sunkara, R., Faller, B., Isbell, J. M., Hugec, V., Shipstone, A., McGary, E. C., Clarke, J. M., Talsania, A., Ding, L., Govindan, R., Sands, J. M., Heymach, J. V., Raez, L. E., Malik, S. M., Stinchcombe, T. E., Mandrekar, S. J., Bradley, J., Gerber, D. E., Vokes, E., Gandara, D., Staley, C., & Ramalingam, S. S. (2026). Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer. JAMA. https://doi.org/10.1001/jama.2026.8992

Source records